CrossrefInfokarte
Safety, Efficacy, and Biomarker Exploration in a Phase II Study of Bevacizumab, Oxaliplatin, and Gemcitabine in Recurrent Müllerian Carcinoma
Clinical Ovarian Cancer · 2011
DOI: 10.1016/j.cloc.2011.04.003 ↗Abstract
Kein Abstract verfügbar.
EUVIMED